Prolonged-Release Hydrogel Formulations of Toll-Like Receptor Agonists for Intratumoral Injection to Increase Immunotherapy Response
Invention type: Technology
/
Case number: #23215J
Researchers
Robert Langer
/
Umar Mahmood
/
Eric Wehrenberg-Klee
/
Gabrielle Ndakwah
/
Jan-Georg Rosenboom
/
Avik Som
/
Arijit Basu
/
Giovanni Traverso
Departments: Office of the Institute Professors, David H Koch Institute for Integrative Cancer Res, Department of Mechanical Engineering
Technology Areas: Therapeutics: Small Molecules
Impact Areas: Healthy Living
-
injectable prolonged-release hydrogel formulations of toll-like receptor agonists for intratumoral injection to increase immunotherapy response
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.